Jack Ashton, PhD, is currently the Associate Director of Solid Tumour Cell Therapy at AstraZeneca, where they work as a Clinical Scientist. With extensive pre-clinical and clinical experience in drug development, they have held various roles at AstraZeneca and Novartis, including Senior Scientist in Translational Pathology. Jack's academic journey includes a PhD in Translational Oncogenomics from Cancer Research UK Manchester Institute and a Bachelor's degree from The University of Manchester. They also contributed as an Operations Manager at North West Biotech Initiative and volunteered for UK COVID-19 testing during 2020.
This person is not in the org chart
This person is not in any teams
This person is not in any offices